Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Minoru Shindo is active.

Publication


Featured researches published by Minoru Shindo.


Journal of Pharmacy and Pharmacology | 1977

N-Carboxyphenyl)-4-chloroanthranilic acid disodium salt: a novel anti-arthritic agent without anti-inflammatory and immunosuppressive activities

Yoshiyuki Ohsugi; Shun-Ichi Hata; Mitsuru Tanemura; Toshiaki Nakano; Takashi Matsuno; Yoshio Takagaki; Yasuho Nishii; Minoru Shindo

Adjuvant arthritis in rats is well known as a chronic model of inflammation and has usually been employed in the evaluation of anti-arthritic drugs (Winter, 1965). Cell-mediated immunity is considered to be important for the development of adjuvant arthritis (Eugui & Houssay, 1975; Pearson & Wood, 1959, 1964; Waksman, Pearson & Sharp, 1960; Waksman & Wennersten, 1963). It has been reported that anti-inflammatory and immunosuppressive agents possess prophylactic or therapeutic activity in adjuvant arthritis (Winter, 1965; Glenn, 1966; Winter & Nuss, 1966; Currey & Ziff, 1968; Perper, Alvarez & others, 1971 ; Walz, DiMartino & Misher, 1971 ; Martel, Klicius & Herr, 1974). In this article we describe a new type of anti-arthritic agent, N-(2-carboxyphenyl)-4-chloroanthranilic acid disodium salt (CCA), which inhibits adjuvant arthritis in rats, in spite of its lack of both anti-inflammatory and immunosuppressive activities. Male Sprague-Dawley rats (8 weeks old) were purchased from Clea Japan, Inc. Adjuvant arthritis was induced by intradermal injection of 0.5 mg of heat-killed Mycobacterium tuberculosis cells suspended in liquid paraffin into the tails of rats.


Journal of The Chemical Society-perkin Transactions 1 | 1979

Synthetic studies of vitamin D3 analogues from bile acids. Part 3. Syntheses of 1α,25-, 1α,24R-, and 1α,24S-dihydroxycholecalciferols from lithocholic acid and their biological activities

Kiyoshige Ochi; Isao Matsunaga; Hiroyuki Nagano; Masafumi Fukushima; Minoru Shindo; Chikara Kaneko; Masayuki Ishikawa; Hector F. DeLuca

Syntheses of 1α,25-, 1α,24R-, and 1α,24S-dihydroxycholecalciferols from lithocholic acid via the analogous 1,4,6-trien-3-ones by application of Kanekos procedure are described. A new synthesis of 1α,25-dihydroxycholecalciferol from lithocholic acid via the 1,4-dien-3-one is also reported. The biological activities of the three cholecalciferols were tested.


Journal of The Chemical Society-perkin Transactions 1 | 1979

Synthetic studies of vitamin D3 analogues from bile acids. Part 2. Syntheses of cholesta-1,4-dien- and -1,4,6-trien-3-ones having a 24-and/or 25-hydroxylated side chain from lithocholic acid

Kiyoshige Ochi; Isao Matsunaga; Minoru Shindo; Chikara Kaneko

Syntheses of 3α-hydroxy-5β-cholestanes having a 25-, 24R-, or 24S-hydroxy group [(13), (6a and b)] or a 24,25-dihydroxy group [(14)] from lithocholic acid (1) are described. These hydroxylated cholestanes were converted to the 1,4-dien-3-ones (15), (10a and b), and (16), and then to the 1,4,6-trien-3-ones (18), (11a and b), and (19) by normal dehydrogenation procedures without affecting the side chains.


Steroids | 1977

Synthesis of desmosterol and epidesmosterol from hyodeoxycholic acid

Kiyoshige Ochi; Isao Matsunaga; Minoru Shindo; C. Kaneko

A new synthesis of desmosterol was described using hyodeoxycholic acid (3alpha,6alpha-dihydroxy-5beta-cholanic acid) as a starting material. Epidesmosterol (3alpha-hydroxycholesta-5,24-diene) was also synthesized for the first time from the same starting material.


Archive | 1978

Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use

Hiroyuki Nagano; Takashi Mori; Sakae Takaku; Isao Matsunaga; Tatsuo Kujirai; Toshichika Ogasawara; Shigeru Sugano; Minoru Shindo


Archive | 1975

1-Aminoalkyl, 3-phenyl indazoles

Yasuo Fujimura; Hiroyuki Nagano; Minoru Shindo; Morio Kakimoto; Tsuneo Iwasaki; Yugo Ikeda


Archive | 1981

Novel uracil derivatives, process for preparing the same and a pharmaceutical composition containing the same

Kiyoshige Ochi; Katsuhito Miyamoto; Hiroki Mitsui; Yumiko Tsuruma; Isao Matsunaga; Takashi Matsuno; Shigeru Takanashi; Minoru Shindo


Archive | 1975

Pharmaceutical composition and method of the use thereof

Takashi Mori; Sakae Takaku; Nobuhiro Oi; Minoru Shindo; Takeaki Hirano; Shigeyuki Kataoka; Kouji Furuno


Archive | 1981

Pyrazoloindazole derivatives and pharmaceutical composition containing the same

Fujimura Yasuo; Tanaka Sadao; Matsunaga Isao; Yasuyuki Shiraki; Yugo Ikeda; Tamotsu Yamazaki; Yasuhiro Ohba; Kazushige Sakai; Shun-Ichi Hata; Minoru Shindo


Archive | 1975

PHTHALAZINE DERIVATIVES AND SALTS THEREOF

Yasuho Nishii; Shun-Ichi Hata; Kiyoshige Wakabayashi; Koji Mizuno; Akio Yoshida; Minoru Shindo

Collaboration


Dive into the Minoru Shindo's collaboration.

Top Co-Authors

Avatar

Isao Matsunaga

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Hiroyuki Nagano

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Kiyoshige Ochi

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Kanji Moro

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Teizo Shinozaki

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Sakae Takaku

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Chikara Kaneko

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Haruki Ogawa

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Bunya Aoki

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Takashi Mori

Chugai Pharmaceutical Co.

View shared research outputs
Researchain Logo
Decentralizing Knowledge